Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 17, 2023

BUY
$63.71 - $70.74 $51,159 - $56,804
803 Added 4.08%
20,494 $1.31 Million
Q1 2023

May 11, 2023

BUY
$65.71 - $74.53 $426,917 - $484,221
6,497 Added 49.24%
19,691 $1.36 Million
Q4 2022

Feb 09, 2023

BUY
$68.48 - $81.09 $299,736 - $354,930
4,377 Added 49.64%
13,194 $949,000
Q3 2022

Nov 07, 2022

BUY
$0.13 - $76.84 $59 - $35,269
459 Added 5.49%
8,817 $627,000
Q2 2022

Aug 12, 2022

SELL
$72.62 - $79.98 $870,931 - $959,200
-11,993 Reduced 58.93%
8,358 $644,000
Q1 2022

May 10, 2022

BUY
$61.48 - $73.72 $1.25 Million - $1.5 Million
20,351 New
20,351 $1.49 Million
Q1 2021

May 05, 2021

SELL
$59.34 - $66.74 $1.26 Million - $1.42 Million
-21,261 Closed
0 $0
Q2 2020

Jul 24, 2020

BUY
$54.82 - $64.09 $390,318 - $456,320
7,120 Added 50.35%
21,261 $1.25 Million
Q4 2019

Jan 31, 2020

SELL
$49.21 - $64.19 $350,375 - $457,032
-7,120 Reduced 33.49%
14,141 $908,000
Q4 2018

Jan 23, 2019

SELL
$48.76 - $63.23 $42,421 - $55,010
-870 Reduced 3.93%
21,261 $1.11 Million
Q3 2018

Oct 31, 2018

BUY
$55.19 - $62.25 $33,114 - $37,350
600 Added 2.79%
22,131 $1.37 Million
Q1 2018

Apr 30, 2018

SELL
$59.92 - $68.98 $5,992 - $6,898
-100 Reduced 0.46%
21,531 $1.36 Million
Q4 2017

Feb 07, 2018

BUY
$59.94 - $65.35 $16,183 - $17,644
270 Added 1.26%
21,631 $1.33 Million
Q3 2017

Nov 15, 2017

BUY
$55.23 - $63.74 $1.18 Million - $1.36 Million
21,361
21,361 $1.36 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Camarda Financial Advisors, LLC Portfolio

Follow Camarda Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camarda Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camarda Financial Advisors, LLC with notifications on news.